MAPK kinase 3 specifically regulates FcεRI-mediated IL-4 production by mast cells

Journal of Immunology

Volumn 187, Issue 6, 2011, Pages 3374-3382

  MacNeil, Adam J ^a   Yang, Yong Jun ^b   Lin, Tong Jun ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; FC EPSILON RECEPTOR I; IMMUNOGLOBULIN E; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE; IL4 GENE; IN VIVO STUDY; INFLAMMATION; MAST CELL; MOUSE; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; CELL DEGRANULATION; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-4; MAP KINASE KINASE 3; MAST CELLS; MICE; MICE, KNOCKOUT; PASSIVE CUTANEOUS ANAPHYLAXIS; PROTEIN ARRAY ANALYSIS; RECEPTORS, IGE; SIGNAL TRANSDUCTION;

EID: 80053068928     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003126     Document Type: Article

References (31)

1. Kawakami, T., and S. J. Galli. 2002. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2: 773-786. (Pubitemid 37328717)
2. Gilfillan, A. M., and C. Tkaczyk. 2006. Integrated signalling pathways for mastcell activation. Nat. Rev. Immunol. 6: 218-230. (Pubitemid 43290991)
3. Galli, S. J., M. Tsai, and A. M. Piliponsky. 2008. The development of allergic inflammation. Nature 454: 445-454.
4. Kinet, J. P. 1999. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu. Rev. Immunol. 17: 931-972.
5. Eiseman, E., and J. B. Bolen. 1992. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature 355: 78-80.
6. Parravicini, V., M. Gadina, M. Kovarova, S. Odom, C. Gonzalez-Espinosa, Y. Furumoto, S. Saitoh, L. E. Samelson, J. J. O'Shea, and J. Rivera. 2002. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat. Immunol. 3: 741-748.
7. Hutchinson, L. E., and M. A. McCloskey. 1995. Fc epsilon RI-mediated induction of nuclear factor of activated T-cells. J. Biol. Chem. 270: 16333-16338.
8. Marquardt, D. L., and L. L. Walker. 2000. Dependence of mast cell IgEmediated cytokine production on nuclear factor-kappaB activity. J. Allergy Clin. Immunol. 105: 500-505. (Pubitemid 30169908)
9. Brancho, D., N. Tanaka, A. Jaeschke, J. J. Ventura, N. Kelkar, Y. Tanaka, M. Kyuuma, T. Takeshita, R. A. Flavell, and R. J. Davis. 2003. Mechanism of p38 MAP kinase activation in vivo. Genes Dev. 17: 1969-1978. (Pubitemid 36999324)
10. Cook, R., C. C. Wu, Y. J. Kang, and J. Han. 2007. The role of the p38 pathway in adaptive immunity. Cell. Mol. Immunol. 4: 253-259.
11. Li, B., M. R. Power, and T. J. Lin. 2006. De novo synthesis of early growth response factor-1 is required for the full responsiveness of mast cells to produce TNF and IL-13 by IgE and antigen stimulation. Blood 107: 2814-2820.
12. Decker, E. L., N. Nehmann, E. Kampen, H. Eibel, P. F. Zipfel, and C. Skerka. 2003. Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression. Nucleic Acids Res. 31: 911-921. (Pubitemid 36240429)
13. Chapman, N. R., and N. D. Perkins. 2000. Inhibition of the RelA(p65) NFkappaB subunit by Egr-1. J. Biol. Chem. 275: 4719-4725. (Pubitemid 30108860)
14. Lu, H. T., D. D. Yang, M. Wysk, E. Gatti, I. Mellman, R. J. Davis, and R. A. Flavell. 1999. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 18: 1845-1857. (Pubitemid 29158528)
15. Nagai, H., T. Abe, I. Yamaguchi, K. Mito, M. Tsunematsu, M. Kimata, and N. Inagaki. 2000. Role of mast cells in the onset of IgE-mediated late-phase cutaneous response in mice. J. Allergy Clin. Immunol. 106: S91-S98. (Pubitemid 30482841)
16. Ng, S. W., J. di Capite, K. Singaravelu, and A. B. Parekh. 2008. Sustained activation of the tyrosine kinase Syk by antigen in mast cells requires local Ca2+ influx through Ca2+ release-activated Ca2+ channels. J. Biol. Chem. 283: 31348-31355.
17. Li, B., J. Berman, J. T. Tang, and T. J. Lin. 2007. The early growth response factor-1 is involved in stem cell factor (SCF)-induced interleukin 13 production by mast cells, but is dispensable for SCF-dependent mast cell growth. J. Biol. Chem. 282: 22573-22581. (Pubitemid 47267355)
18. Feldmann, M. 2008. Many cytokines are very useful therapeutic targets in disease. J. Clin. Invest. 118: 3533-3536.
19. Brown, M. A., and J. Hural. 1997. Functions of IL-4 and control of its expression. Crit. Rev. Immunol. 17: 1-32. (Pubitemid 27068806)
20. Mohapatra, S. S., M. Qazi, and G. Hellermann. 2010. Immunotherapy for allergies and asthma: present and future. Curr. Opin. Pharmacol. 10: 276-288.
21. Weiss, D. L., and M. A. Brown. 2001. Regulation of IL-4 production in mast cells: a paradigm for cell-type-specific gene expression. Immunol. Rev. 179: 35-47. (Pubitemid 32175084)
22. Gauchat, J. F., S. Henchoz, G. Mazzei, J. P. Aubry, T. Brunner, H. Blasey, P. Life, D. Talabot, L. Flores-Romo, J. Thompson, et al. 1993. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365: 340-343. (Pubitemid 23288974)
23. Plaut, M., J. H. Pierce, C. J. Watson, J. Hanley-Hyde, R. P. Nordan, and W. E. Paul. 1989. Mast cell lines produce lymphokines in response to crosslinkage of Fc epsilon RI or to calcium ionophores. Nature 339: 64-67. (Pubitemid 19115894)
24. Inoue, T., D. L. Boyle, M. Corr, D. Hammaker, R. J. Davis, R. A. Flavell, and G. S. Firestein. 2006. Mitogen-activated protein kinase kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis. Proc. Natl. Acad. Sci. USA 103: 5484-5489.
25. Remy, G., A. M. Risco, F. A. Iñesta-Vaquera, B. González-Terán, G. Sabio, R. J. Davis, and A. Cuenda. 2010. Differential activation of p38MAPK isoforms by MKK6 and MKK3. Cell. Signal. 22: 660-667.
26. Enslen, H., J. Raingeaud, and R. J. Davis. 1998. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem. 273: 1741-1748. (Pubitemid 28133705)
27. Lohoff, M., M. Giaisi, R. Köhler, B. Casper, P. H. Krammer, and M. Li-Weber. 2010. Early growth response protein-1 (Egr-1) is preferentially expressed in T helper type 2 (Th2) cells and is involved in acute transcription of the Th2 cytokine interleukin-4. J. Biol. Chem. 285: 1643-1652.
28. Yang, Y. J., W. Chen, A. Edgar, B. Li, J. D. Molkentin, J. N. Berman, and T. J. Lin. 2009. Rcan1 negatively regulates Fc epsilonRI-mediated signaling and mast cell function. J. Exp. Med. 206: 195-207.
29. Tamma, S. M., K. W. Chung, T. Patel, S. P. Balan, and S. Pahwa. 2006. p38 MAPK plays a role in IL-4 synthesis in jacalin plus CD28-stimulated CD4+ T cells-II. J. Leukoc. Biol. 79: 1339-1347. (Pubitemid 44835569)
30. Borish, L. C., H. S. Nelson, J. Corren, G. Bensch, W. W. Busse, J. B. Whitmore, J. M. Agosti; IL-4R Asthma Study Group. 2001. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J. Allergy Clin. Immunol. 107: 963-970. (Pubitemid 32523334)
31. Kumar, S., J. Boehm, and J. C. Lee. 2003. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2: 717-726. (Pubitemid 37361787)